|
Varghese, Susan; Rabkin, Samuel D (2002) Oncolytic herpes simplex virus vectors for cancer virotherapy. Cancer Gene Ther 9:967-78
|
|
New, K C; Rabkin, S D (1998) GABA synthesis in astrocytes after infection with defective herpes simplex virus vectors expressing glutamic acid decarboxylase 65 or 67. J Neurochem 71:2304-12
|
|
Toda, M; Martuza, R L; Kojima, H et al. (1998) In situ cancer vaccination: an IL-12 defective vector/replication-competent herpes simplex virus combination induces local and systemic antitumor activity. J Immunol 160:4457-64
|
|
New, K C; Gale, K; Martuza, R L et al. (1998) Novel synthesis and release of GABA in cerebellar granule cell cultures after infection with defective herpes simplex virus vectors expressing glutamic acid decarboxylase. Brain Res Mol Brain Res 61:121-35
|
|
Miyatake, S; Martuza, R L; Rabkin, S D (1997) Defective herpes simplex virus vectors expressing thymidine kinase for the treatment of malignant glioma. Cancer Gene Ther 4:222-8
|
|
Rabkin, S D; Mineta, T; Miyatake, S et al. (1996) Gene therapy: targeting tumor cells for destruction. Hum Cell 9:265-76
|
|
Yazaki, T; Martuza, R L; Rabkin, S D (1996) Expression of L1 in primary astrocytes via a defective herpes simplex virus vector promotes neurite outgrowth and neural cell migration. Brain Res Mol Brain Res 43:311-20
|
